Medical Industry Innovation Institute

Organization Overview

Institution Name
Medical Industry Innovation Institute (Mi3)
Date of Establishment
5th, September 2011
The medical industry innovation institute was established in September 2011, with its mission to promote development of medical industry which encompassess pharmaceutical, medical device, medical technolgy, and medical/healthcare services industry.
Board Member

Hiromichi Kimura, Ph.D.
Project Professor of the University of Tokyo, Institute for Future Initiatives

Executive Board Members

Kihito Takahashi, M.D., Ph.D.
R&D/Medical Japan Hub General Manager, Sobi™ Japan

Takahisa Murakami
President, Japan Pharmaceutical Information Center

Toichi Takenaka, Ph.D.
Chairman of the Bord, Japan Microbiome Consortium(JMBC)

Masuhiro Kato, Ph.D.
Representative Director, President, MiraBilogics Inc.

Kazunori Kataoka, Ph.D.
Director General of Innovation Center of NanoMedicine(iCONM)
Professor Emeritus, the University of Tokyo

Tatsuro Irimura, Ph.D.
Professor, Juntendo University Graduate School of Medicine
Chairman of the Board, Tokyo Foundation for Pharmaceutical Sciences
Professor Emeritus, the University of Tokyo


Tetsuro Toriumi

Expected Participants
Participation from following sectors as board member, advisor, corporate member, or individual member is expected.
  • Government agencies, independent administrative institutions, affiliated organizations of government agencies, affiliated organizations of local governments
  • Business community, industry groups
  • Pharmaceutical, medical device, food, consumer goods, medical services companies
  • Logistics, financial, human resource companies with strong focus in healthcare
  • Information services companies (think tank, media, consulting) with strong focus in healthcare
  • Healthcare professionals, medical institutions, associations for healthcare professionals, academic societies for healthcare professionals
  • Academic experts, educational corporation
  • Charity groups, etc.
Overview Chart